Catalyst Wire Dossier Catalyst Wire Dossier

INLEXZO

Gemcitabine intravesical · Janssen Biotech, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INLEXZO, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: FDA Approved: INLEXZO — Original Application (Janssen Biotech, Inc)

See pricing